These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 12200773)
21. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging. Mori K; Scheidler J; Helmberger T; Holzknecht N; Schauer R; Schirren CA; Bittmann I; Dugas M; Reiser M AJR Am J Roentgenol; 2002 Oct; 179(4):1045-51. PubMed ID: 12239063 [TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353 [TBL] [Abstract][Full Text] [Related]
23. An unusual hyperplastic hepatocellular nodule in a patient with hepatitis C virus-related liver cirrhosis. Kageyama F; Kobayashi Y; Kawasaki T; Nakamura H; Baba S; Nakamura S; Nakashima O; Kojiro M Am J Gastroenterol; 1998 Dec; 93(12):2588-93. PubMed ID: 9860435 [TBL] [Abstract][Full Text] [Related]
24. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. Kim CK; Lim JH; Lee WJ J Ultrasound Med; 2001 Feb; 20(2):99-104. PubMed ID: 11211142 [TBL] [Abstract][Full Text] [Related]
25. Newly developed hepatocellular carcinoma (HCC) in chronic liver disease: MR imaging findings before the diagnosis of HCC. Yu JS; Cho ES; Kim KH; Chung WS; Park MS; Kim KW J Comput Assist Tomogr; 2006; 30(5):765-71. PubMed ID: 16954925 [TBL] [Abstract][Full Text] [Related]
27. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US. Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038 [TBL] [Abstract][Full Text] [Related]
28. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. Lim JH; Kim CK; Lee WJ; Park CK; Koh KC; Paik SW; Joh JW AJR Am J Roentgenol; 2000 Sep; 175(3):693-8. PubMed ID: 10954452 [TBL] [Abstract][Full Text] [Related]
29. Liver focal lesions and hepatocellular carcinoma in cirrhotic patients: from screening to diagnosis. Zardi EM; Uwechie V; Picardi A; Costantino S Clin Ter; 2001; 152(3):185-8. PubMed ID: 11692538 [TBL] [Abstract][Full Text] [Related]
30. Hepatocellular nodules in liver cirrhosis: MR evaluation. Lee JM; Choi BI Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975 [TBL] [Abstract][Full Text] [Related]
31. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. de Lédinghen V; Laharie D; Lecesne R; Le Bail B; Winnock M; Bernard PH; Saric J; Couzigou P; Balabaud C; Bioulac-Sage P; Drouillard J Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):159-65. PubMed ID: 11981340 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10-20 mm) detected in the cirrhotic liver at screening ultrasound. Abd Alkhalik Basha M; Abd El Aziz El Sammak D; El Sammak AA Clin Radiol; 2017 Oct; 72(10):901.e1-901.e11. PubMed ID: 28673446 [TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448 [TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577 [TBL] [Abstract][Full Text] [Related]
35. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [TBL] [Abstract][Full Text] [Related]
36. How to detect hepatocellular carcinoma in cirrhosis. Ward J; Robinson PJ Eur Radiol; 2002 Sep; 12(9):2258-72. PubMed ID: 12195479 [TBL] [Abstract][Full Text] [Related]
37. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis. Park MJ; Kim YK; Lee MH; Lee JH Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300 [TBL] [Abstract][Full Text] [Related]
38. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081 [TBL] [Abstract][Full Text] [Related]
39. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patients. Caturelli E; Pompili M; Bartolucci F; Siena DA; Sperandeo M; Andriulli A; Bisceglia M Radiology; 2001 Aug; 220(2):337-42. PubMed ID: 11477234 [TBL] [Abstract][Full Text] [Related]
40. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound. Quaia E Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]